Literature DB >> 10727892

Recombinant live Salmonella spp. for human vaccination against heterologous pathogens.

D Bumann1, C Hueck, T Aebischer, T F Meyer.   

Abstract

Live attenuated Salmonella spp. are promising candidates as oral vaccine delivery systems for heterologous antigens. Clinical trials have demonstrated that this approach is feasible for human vaccinations but further optimisation is necessary to obtain a better efficacy. Here, we discuss how existing clinical and pre-clinical data can be used to guide such optimisation efforts.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10727892     DOI： 10.1111/j.1574-695X.2000.tb01450.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN： 0928-8244


  16 in total

Review 1.  Bacterial infectious disease control by vaccine development.

Authors:  Roy Curtiss
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

2.  Evaluation of protective efficacy of live attenuated Salmonella enterica serovar Gallinarum vaccine strains against fowl typhoid in chickens.

Authors:  Paweł Laniewski; Arindam Mitra; Kemal Karaca; Ayub Khan; Rajeev Prasad; Roy Curtiss; Kenneth L Roland
Journal:  Clin Vaccine Immunol       Date:  2014-07-02

3.  In vivo visualization of bacterial colonization, antigen expression, and specific T-cell induction following oral administration of live recombinant Salmonella enterica serovar Typhimurium.

Authors:  D Bumann
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Surface display of foreign epitopes on the Lactobacillus brevis S-layer.

Authors:  Silja Avall-Jääskeläinen; Kari Kylä-Nikkilä; Minna Kahala; Terhi Miikkulainen-Lahti; Airi Palva
Journal:  Appl Environ Microbiol       Date:  2002-12       Impact factor: 4.792

Review 5.  Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment.

Authors:  Vafa Shahabi; Paulo C Maciag; Sandra Rivera; Anu Wallecha
Journal:  Bioeng Bugs       Date:  2010-01-04

6.  Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses.

Authors:  D Bumann
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 7.  Bacillus subtilis: a temperature resistant and needle free delivery system of immunogens.

Authors:  Hellen Amuguni; Saul Tzipori
Journal:  Hum Vaccin Immunother       Date:  2012-06-15       Impact factor: 3.452

Review 8.  An Update on "Reverse Vaccinology": The Pathway from Genomes and Epitope Predictions to Tailored, Recombinant Vaccines.

Authors:  Marcin Michalik; Bardya Djahanschiri; Jack C Leo; Dirk Linke
Journal:  Methods Mol Biol       Date:  2022

9.  Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.

Authors:  Dominique Fraillery; David Baud; Susana Yuk-Ying Pang; John Schiller; Martine Bobst; Nathalie Zosso; Françoise Ponci; Denise Nardelli-Haefliger
Journal:  Clin Vaccine Immunol       Date:  2007-08-08

10.  Transcriptional pathways associated with the slow growth phenotype of transformed Anaplasma marginale.

Authors:  Sebastián Aguilar Pierlé; Gena Kenitra Hammac; Guy H Palmer; Kelly A Brayton
Journal:  BMC Genomics       Date:  2013-04-22       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.